Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

NCT00570323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Arimidex
DRUG: Faslodex

Sponsor

Mothaffar Rimawi

Collaborators

[object Object]